Tirilazad

From Wikipedia, the free encyclopedia

Tirilazad
Systematic (IUPAC) name
(8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
Identifiers
CAS number 110101-66-1
ATC code N07XX01
PubChem 104903
Chemical data
Formula C38H52N6O2 
Mol. mass 624.859 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Tirilazad is a drug proposed for use in the treatment of stroke, though results so far have been mixed.[1]

[edit] References

  1. ^ Tirilazad for acute ischaemic stroke. Retrieved on 2007-07-28.